Procaps Group (PROC) Competitors

Eton Pharmaceuticals (NASDAQ:ETON) and Procaps Group (NASDAQ:PROC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation, community ranking and earnings.

Do analysts rate ETON or PROC?

Eton Pharmaceuticals currently has a consensus target price of $24.00, suggesting a potential upside of 65.60%. Given Eton Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Eton Pharmaceuticals is more favorable than Procaps Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eton Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33
Procaps Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has more risk and volatility, ETON or PROC?

Eton Pharmaceuticals has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Comparatively, Procaps Group has a beta of -0.05, meaning that its stock price is 105% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in ETON or PROC?

27.9% of Eton Pharmaceuticals shares are held by institutional investors. 14.9% of Eton Pharmaceuticals shares are held by company insiders. Comparatively, 19.9% of Procaps Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the media favor ETON or PROC?

In the previous week, Eton Pharmaceuticals had 1 more articles in the media than Procaps Group. MarketBeat recorded 1 mentions for Eton Pharmaceuticals and 0 mentions for Procaps Group. Eton Pharmaceuticals' average media sentiment score of 0.74 beat Procaps Group's score of 0.00 indicating that Eton Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Eton Pharmaceuticals	Positive
Procaps Group	Neutral

Is ETON or PROC more profitable?

Procaps Group has a net margin of 0.00% compared to Eton Pharmaceuticals' net margin of -15.81%. Procaps Group's return on equity of 0.00% beat Eton Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eton Pharmaceuticals	-15.81%	-36.29%	-16.84%
Procaps Group	N/A	N/A	N/A

Does the MarketBeat Community believe in ETON or PROC?

Eton Pharmaceuticals received 92 more outperform votes than Procaps Group when rated by MarketBeat users. Likewise, 65.07% of users gave Eton Pharmaceuticals an outperform vote while only 37.50% of users gave Procaps Group an outperform vote.

Company	Underperform	Outperform
Eton Pharmaceuticals	Outperform Votes 95 65.07%	Underperform Votes 51 34.93%
Procaps Group	Outperform Votes 3 37.50%	Underperform Votes 5 62.50%

Which has better earnings and valuation, ETON or PROC?

Procaps Group has higher revenue and earnings than Eton Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eton Pharmaceuticals	$31.64M	11.93	-$940K	-$0.22	-65.88
Procaps Group	$409.92M	0.26	$42.54M	N/A	N/A

Summary

Eton Pharmaceuticals beats Procaps Group on 11 of the 17 factors compared between the two stocks.